S&P 500 Futures
(-0.74%) 5 069.75 points
Dow Jones Futures
(-0.23%) 38 591 points
Nasdaq Futures
(-1.33%) 17 429 points
Oil
(0.18%) $82.96
Gas
(-0.42%) $1.646
Gold
(-0.33%) $2 330.70
Silver
(-0.52%) $27.21
Platinum
(-0.47%) $911.50
USD/EUR
(-0.18%) $0.933
USD/NOK
(-0.18%) $10.96
USD/GBP
(-0.21%) $0.801
USD/RUB
(0.17%) $92.48

Realtime updates for Celon Pharma S.A. [CLN.WA]

Exchange: WSE Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-04-26)

Expected move: +/- 0.00%

Last Updated24 Apr 2024 @ 11:00

-0.40% PLN 15.00

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 11:00):

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments...

Stats
Today's Volume 10 430.00
Average Volume 18 736.00
Market Cap 765.85M
EPS PLN-0.130 ( 2023-11-22 )
Next earnings date ( PLN0 ) 2024-04-26
Last Dividend PLN0.0900 ( 2023-06-29 )
Next Dividend PLN0 ( N/A )
P/E -30.00
ATR14 PLN0.0630 (0.41%)

Volume Correlation

Long: -0.09 (neutral)
Short: -0.03 (neutral)
Signal:(53.668) Neutral

Celon Pharma S.A. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Celon Pharma S.A. Correlation - Currency/Commodity

The country flag 0.57
( weak )
The country flag 0.49
( neutral )
The country flag 0.00
( neutral )
The country flag 0.58
( weak )
The country flag 0.40
( neutral )
The country flag 0.23
( neutral )

Celon Pharma S.A. Financials

Annual 2022
Revenue: PLN161.92M
Gross Profit: PLN95.45M (58.95 %)
EPS: PLN-0.770
Q3 2023
Revenue: PLN42.50M
Gross Profit: PLN26.17M (61.58 %)
EPS: PLN-0.130
Q2 2023
Revenue: PLN42.23M
Gross Profit: PLN26.06M (61.71 %)
EPS: PLN0.180
Q1 2023
Revenue: PLN39.01M
Gross Profit: PLN22.70M (58.20 %)
EPS: PLN-0.190

Financial Reports:

No articles found.

Celon Pharma S.A. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
PLN0
(N/A)
PLN0
(N/A)
PLN0
(N/A)
PLN0.0900
(N/A)
PLN0
(N/A)
PLN0
(N/A)
PLN0
(N/A)
PLN0
(N/A)
PLN0
(N/A)
PLN0
(N/A)

Celon Pharma S.A. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.52 - low (50.28%) | Divividend Growth Potential Score: 0.137 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend PLN0.170 2017-05-31
Last Dividend PLN0.0900 2023-06-29
Next Dividend PLN0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 7 --
Total Paid Out PLN1.110 --
Avg. Dividend % Per Year 0.00% --
Score 1.27 --
Div. Sustainability Score 4.52
Div.Growth Potential Score 0.137
Div. Directional Score 2.33 --
Next Divdend (Est)
(2025-04-08)
PLN0.0386 Estimate 3.10 %
Dividend Stability
0.25 Very Poor
Dividend Score
1.27
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for WSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
VRC.WA Ex Dividend Knight 2023-08-29 Monthly 0 0.00%
GPP.WA Ex Dividend Junior 2023-06-29 Annually 0 0.00%
R22.WA Ex Dividend Junior 2023-08-29 Annually 0 0.00%
COG.WA Ex Dividend Junior 2023-05-04 Sporadic 0 0.00%
OEX.WA Ex Dividend Junior 2023-07-06 Sporadic 0 0.00%
BHW.WA Ex Dividend Junior 2023-05-05 Annually 0 0.00%
LSI.WA Ex Dividend Junior 2023-08-16 Sporadic 0 0.00%
ASB.WA Ex Dividend Knight 2023-06-23 Semi-Annually 0 0.00%
IFI.WA Ex Dividend Knight 2023-09-06 Quarterly 0 0.00%
WWL.WA Ex Dividend Knight 2023-07-13 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.1141.500-2.28-3.42[0 - 0.5]
returnOnAssetsTTM-0.03331.200-1.109-1.331[0 - 0.3]
returnOnEquityTTM-0.04081.500-1.565-2.35[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.7440.8006.285.02[1 - 3]
quickRatioTTM1.4380.8006.255.00[0.8 - 2.5]
cashRatioTTM0.2151.5009.9210.00[0.2 - 2]
debtRatioTTM0.0289-1.5009.52-10.00[0 - 0.6]
interestCoverageTTM-5.951.000-3.31-3.31[3 - 30]
operatingCashFlowPerShareTTM0.1332.009.9610.00[0 - 30]
freeCashFlowPerShareTTM-0.6052.00-0.303-0.605[0 - 20]
debtEquityRatioTTM0.0361-1.5009.86-10.00[0 - 2.5]
grossProfitMarginTTM0.5981.0003.373.37[0.2 - 0.8]
operatingProfitMarginTTM-0.09361.000-3.87-3.87[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4071.0008.858.85[0.2 - 2]
assetTurnoverTTM0.2920.800-1.386-1.109[0.5 - 2]
Total Score4.52

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-40.721.000-4.210[1 - 100]
returnOnEquityTTM-0.04082.50-1.006-2.35[0.1 - 1.5]
freeCashFlowPerShareTTM-0.6052.00-0.202-0.605[0 - 30]
dividendYielPercentageTTM0.5901.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.1332.009.9610.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.5241.500-6.820[0.5 - 2]
operatingCashFlowSalesRatioTTM0.04031.000-1.4930[0.1 - 0.5]
Total Score0.137

Celon Pharma S.A.

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators